Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
Identifieur interne : 000146 ( PubMed/Checkpoint ); précédent : 000145; suivant : 000147Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
Auteurs : Akosua Adom Agyeman [Ghana] ; Richard Ofori-Asenso [Ghana] ; Andy Mprah [Ghana] ; George Ashiagbor [Ghana]Source :
- BMC infectious diseases [ 1471-2334 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte, Anticorps de l'hépatite C (sang), Co-infection (épidémiologie), Donneurs de sang, Ghana (épidémiologie), Humains, Hépatite C (épidémiologie), Hépatite C chronique (épidémiologie), Infections opportunistes liées au SIDA (microbiologie), Infections opportunistes liées au SIDA (épidémiologie), Infections à VIH (épidémiologie), Population rurale, Population urbaine, Taille d'échantillon, Études séroépidémiologiques, Études transversales.
- MESH :
- microbiologie : Infections opportunistes liées au SIDA.
- sang : Anticorps de l'hépatite C.
- épidémiologie : Co-infection, Ghana, Hépatite C, Hépatite C chronique, Infections opportunistes liées au SIDA, Infections à VIH.
- Adulte, Donneurs de sang, Humains, Population rurale, Population urbaine, Taille d'échantillon, Études séroépidémiologiques, Études transversales.
English descriptors
- KwdEn :
- AIDS-Related Opportunistic Infections (epidemiology), AIDS-Related Opportunistic Infections (microbiology), Adult, Blood Donors, Coinfection (epidemiology), Cross-Sectional Studies, Ghana (epidemiology), HIV Infections (epidemiology), Hepatitis C (epidemiology), Hepatitis C Antibodies (blood), Hepatitis C, Chronic (epidemiology), Humans, Rural Population, Sample Size, Seroepidemiologic Studies, Urban Population.
- MESH :
- chemical , blood : Hepatitis C Antibodies.
- epidemiology : AIDS-Related Opportunistic Infections, Coinfection, Ghana, HIV Infections, Hepatitis C, Hepatitis C, Chronic.
- microbiology : AIDS-Related Opportunistic Infections.
- Adult, Blood Donors, Cross-Sectional Studies, Humans, Rural Population, Sample Size, Seroepidemiologic Studies, Urban Population.
Abstract
To fully understand the burden of hepatitis C (HCV) infection in Ghana towards informing appropriate preventive measures, accurate prevalence estimates are needed. In this study, we estimate the prevalence of chronic HCV infection by systematically reviewing primary studies published between 1995 and 2015.
DOI: 10.1186/s12879-016-1708-7
PubMed: 27507267
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27507267Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.</title><author><name sortKey="Agyeman, Akosua Adom" sort="Agyeman, Akosua Adom" uniqKey="Agyeman A" first="Akosua Adom" last="Agyeman">Akosua Adom Agyeman</name><affiliation wicri:level="1"><nlm:affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra</wicri:regionArea><wicri:noRegion>Weija-Accra</wicri:noRegion></affiliation></author><author><name sortKey="Ofori Asenso, Richard" sort="Ofori Asenso, Richard" uniqKey="Ofori Asenso R" first="Richard" last="Ofori-Asenso">Richard Ofori-Asenso</name><affiliation wicri:level="1"><nlm:affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana. asensox215@gmail.com.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra</wicri:regionArea><wicri:noRegion>Weija-Accra</wicri:noRegion></affiliation></author><author><name sortKey="Mprah, Andy" sort="Mprah, Andy" uniqKey="Mprah A" first="Andy" last="Mprah">Andy Mprah</name><affiliation wicri:level="1"><nlm:affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra</wicri:regionArea><wicri:noRegion>Weija-Accra</wicri:noRegion></affiliation></author><author><name sortKey="Ashiagbor, George" sort="Ashiagbor, George" uniqKey="Ashiagbor G" first="George" last="Ashiagbor">George Ashiagbor</name><affiliation wicri:level="1"><nlm:affiliation>Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Kwame Nkrumah University of Science and Technology, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27507267</idno><idno type="pmid">27507267</idno><idno type="doi">10.1186/s12879-016-1708-7</idno><idno type="wicri:Area/PubMed/Corpus">000115</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000115</idno><idno type="wicri:Area/PubMed/Curation">000115</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000115</idno><idno type="wicri:Area/PubMed/Checkpoint">000115</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000115</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.</title><author><name sortKey="Agyeman, Akosua Adom" sort="Agyeman, Akosua Adom" uniqKey="Agyeman A" first="Akosua Adom" last="Agyeman">Akosua Adom Agyeman</name><affiliation wicri:level="1"><nlm:affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra</wicri:regionArea><wicri:noRegion>Weija-Accra</wicri:noRegion></affiliation></author><author><name sortKey="Ofori Asenso, Richard" sort="Ofori Asenso, Richard" uniqKey="Ofori Asenso R" first="Richard" last="Ofori-Asenso">Richard Ofori-Asenso</name><affiliation wicri:level="1"><nlm:affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana. asensox215@gmail.com.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra</wicri:regionArea><wicri:noRegion>Weija-Accra</wicri:noRegion></affiliation></author><author><name sortKey="Mprah, Andy" sort="Mprah, Andy" uniqKey="Mprah A" first="Andy" last="Mprah">Andy Mprah</name><affiliation wicri:level="1"><nlm:affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra</wicri:regionArea><wicri:noRegion>Weija-Accra</wicri:noRegion></affiliation></author><author><name sortKey="Ashiagbor, George" sort="Ashiagbor, George" uniqKey="Ashiagbor G" first="George" last="Ashiagbor">George Ashiagbor</name><affiliation wicri:level="1"><nlm:affiliation>Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Kwame Nkrumah University of Science and Technology, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author></analytic><series><title level="j">BMC infectious diseases</title><idno type="eISSN">1471-2334</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Opportunistic Infections (epidemiology)</term><term>AIDS-Related Opportunistic Infections (microbiology)</term><term>Adult</term><term>Blood Donors</term><term>Coinfection (epidemiology)</term><term>Cross-Sectional Studies</term><term>Ghana (epidemiology)</term><term>HIV Infections (epidemiology)</term><term>Hepatitis C (epidemiology)</term><term>Hepatitis C Antibodies (blood)</term><term>Hepatitis C, Chronic (epidemiology)</term><term>Humans</term><term>Rural Population</term><term>Sample Size</term><term>Seroepidemiologic Studies</term><term>Urban Population</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Anticorps de l'hépatite C (sang)</term><term>Co-infection (épidémiologie)</term><term>Donneurs de sang</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Hépatite C (épidémiologie)</term><term>Hépatite C chronique (épidémiologie)</term><term>Infections opportunistes liées au SIDA (microbiologie)</term><term>Infections opportunistes liées au SIDA (épidémiologie)</term><term>Infections à VIH (épidémiologie)</term><term>Population rurale</term><term>Population urbaine</term><term>Taille d'échantillon</term><term>Études séroépidémiologiques</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Hepatitis C Antibodies</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Coinfection</term><term>Ghana</term><term>HIV Infections</term><term>Hepatitis C</term><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps de l'hépatite C</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Co-infection</term><term>Ghana</term><term>Hépatite C</term><term>Hépatite C chronique</term><term>Infections opportunistes liées au SIDA</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Blood Donors</term><term>Cross-Sectional Studies</term><term>Humans</term><term>Rural Population</term><term>Sample Size</term><term>Seroepidemiologic Studies</term><term>Urban Population</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Donneurs de sang</term><term>Humains</term><term>Population rurale</term><term>Population urbaine</term><term>Taille d'échantillon</term><term>Études séroépidémiologiques</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To fully understand the burden of hepatitis C (HCV) infection in Ghana towards informing appropriate preventive measures, accurate prevalence estimates are needed. In this study, we estimate the prevalence of chronic HCV infection by systematically reviewing primary studies published between 1995 and 2015.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27507267</PMID><DateCreated><Year>2016</Year><Month>08</Month><Day>10</Day></DateCreated><DateCompleted><Year>2017</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><PubDate><Year>2016</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>391</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-016-1708-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To fully understand the burden of hepatitis C (HCV) infection in Ghana towards informing appropriate preventive measures, accurate prevalence estimates are needed. In this study, we estimate the prevalence of chronic HCV infection by systematically reviewing primary studies published between 1995 and 2015.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis was conducted as per the PRISMA guidelines. Comprehensive searches for hepatitis C prevalence studies for the years 1995-2015 were conducted in PubMed, ScienceDirect, Google Scholar, Africa Journals Online (AJOL) and the WHO African Index Medicus databases. We also searched the websites of the ministry of health and Ghana Health service for non-indexed studies or reports on the subject. Further systematic reference screening of published reviews and retrieved studies were also conducted to identify additional publications not captured through the online searches.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-Four (24) studies from nine regions of Ghana with a combined sample size of 100,782 were analyzed. No study involving participants from Upper West region was retrieved. The national prevalence of chronic HCV was estimated as 3.0 % (95 % CI = 2.6 % to 3.5 %; I(2) = 97.61 %, p < 0. 001). Prevalence rates of chronic HCV infection among blood donors was 2.6 % (95 % CI = 2.1 % to 3.1 %; I(2) = 98.33 %, p < 0.001) with higher prevalence rate estimated for replacement blood donors (RBDs) than voluntary blood donors (RBDs). Among pregnant women and parturients, anti-HCV seroprevalence was estimated as 4.6 % (95 % CI = 1.8 % to 7.5 %; I(2) = 75.74 %, p = 0.016). The national prevalence of HIV/HCV co-infection was also estimated as 2.8 % (95 % CI = 0.4-6 %; I(2) = 65.86 %, p = 0.0053). Regional prevalence of chronic HCV infection were determined for Ashanti (1.5 %, 95 % CI = 1.2 % to 1.9 %; I(2) = 96.24 %, p < 0.001) and Greater Accra (6.4 %, 95 % CI = 4.2 % to 8.6 %; I(2) = I(2) = 88.5 %, P < 0. 001) regions but no estimates were available for the other eight regions. The ascending order of HCV prevalence rates according to years in which studies were conducted was 2006-2010 < 2011-2015 < 1995-2002 < 2001-2005. Higher prevalence of chronic HCV infection was estimated for rural (5.7; 95 % CI 5.0-6.3 %; I(2) = 0, p = 0.804) than urban (2.6 %, 95 % CI = 2.1 % to 3.0 %; I(2) = 97.3 %, p = 0.0001) settings.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study demonstrates a high prevalence of chronic hepatitis C infection in Ghana. This highlights the urgent need for stronger commitments from government and all stakeholders within the country to outline efficient preventive and curative measures towards reducing the overall burden of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Agyeman</LastName><ForeName>Akosua Adom</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofori-Asenso</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana. asensox215@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mprah</LastName><ForeName>Andy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashiagbor</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018937">Hepatitis C Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Can J Gastroenterol Hepatol. 2014 May;28(5):243-50</RefSource><PMID Version="1">24839620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>East Afr Med J. 2004 Apr;81(4):198-201</RefSource><PMID Version="1">15884286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2008 Mar 07;8:33</RefSource><PMID Version="1">18328097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2015 Jul;15(7):819-24</RefSource><PMID Version="1">25957078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2015 May;22(5):461-8</RefSource><PMID Version="1">25394987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Microbiol. 2006 May;55(Pt 5):593-7</RefSource><PMID Version="1">16585647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ghana Med J. 2011 Sep;45(3):97-100</RefSource><PMID Version="1">22282575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Open Forum Infect Dis. 2015 Sep 01;2(4):ofv122</RefSource><PMID Version="1">26566533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2015 Jan;61(1):77-87</RefSource><PMID Version="1">25069599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol Community Health. 1998 Jun;52(6):377-84</RefSource><PMID Version="1">9764259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2007 Nov;47(11):2017-24</RefSource><PMID Version="1">17958530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2015 Feb;62(2):469-76</RefSource><PMID Version="1">25457207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2006 Oct 30;25(20):3443-57</RefSource><PMID Version="1">16345038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1998 Sep-Oct;92(5):496-9</RefSource><PMID Version="1">9861360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Open Forum Infect Dis. 2014 Sep 17;1(2):ofu065</RefSource><PMID Version="1">25734135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Niger J Clin Pract. 2015 Mar-Apr;18(2):163-72</RefSource><PMID Version="1">25665986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2005 Feb;45(2):133-40</RefSource><PMID Version="1">15660820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2010 Feb;50(2):340-3</RefSource><PMID Version="1">19843284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2013 Jun;57(6):2164-70</RefSource><PMID Version="1">23280550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2007 May 7;13(17):2436-41</RefSource><PMID Version="1">17552026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2001 Apr;113(1):37-9</RefSource><PMID Version="1">11328277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2002 May;2(5):293-302</RefSource><PMID Version="1">12062995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 1991 Mar;86(3):335-8</RefSource><PMID Version="1">1847790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2016 Apr;23 (4):244-55</RefSource><PMID Version="1">26477881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2016 Mar 18;16:130</RefSource><PMID Version="1">26987556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5</RefSource><PMID Version="1">22715208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Gastroenterol. 2006 Apr-Jun;27(2):80-3</RefSource><PMID Version="1">17089617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Med Health Sci Res. 2014 Sep;4(5):719-22</RefSource><PMID Version="1">25328781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2002 Sep;40(9):3523-5</RefSource><PMID Version="1">12202610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Pharmacol. 2004 Jan;44(1):20-9</RefSource><PMID Version="1">14681338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Gastroenterol Belg. 2002 Apr-Jun;65(2):83-6</RefSource><PMID Version="1">12148444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Sep 6;327(7414):557-60</RefSource><PMID Version="1">12958120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pan Afr Med J. 2015 Mar 18;20:260</RefSource><PMID Version="1">26161183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 1996 Mar;48(3):278-83</RefSource><PMID Version="1">8801290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Obstet Gynecol. 2008 Jul;199(1):38.e1-9</RefSource><PMID Version="1">18486089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vox Sang. 2001 Apr;80(3):142-7</RefSource><PMID Version="1">11840974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2006 Oct;45(4):529-38</RefSource><PMID Version="1">16879891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2009 Aug 18;151(4):264-9, W64</RefSource><PMID Version="1">19622511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>West Afr J Med. 2000 Oct-Dec;19(4):239-41</RefSource><PMID Version="1">11391831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2012 Jan;84(1):6-10</RefSource><PMID Version="1">22095533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>West Afr J Med. 2006 Jan-Mar;25(1):17-21</RefSource><PMID Version="1">16722353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Recomm Rep. 2003 Feb 7;52(RR-3):1-13, 15; quiz CE1-4</RefSource><PMID Version="1">12585742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Hepatol. 2014 Sep 27;6(9):643-51</RefSource><PMID Version="1">25276280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 1997 Sep;26(3 Suppl 1):43S-47S</RefSource><PMID Version="1">9305663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2009 Apr;49(4):669-75</RefSource><PMID Version="1">19170991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2003 Jul;77(14):7914-23</RefSource><PMID Version="1">12829831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Public Health Rep. 2012 Jul-Aug;127(4):407-21</RefSource><PMID Version="1">22753984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Public Health. 2015 Oct 11;15:1041</RefSource><PMID Version="1">26456626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2011 Jul;18(7):e394-8</RefSource><PMID Version="1">21692952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2012 Oct;52(10):2161-6</RefSource><PMID Version="1">22612858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Infect. 2011 Feb;17(2):107-15</RefSource><PMID Version="1">21091831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr Health Sci. 2015 Sep;15(3):709-13</RefSource><PMID Version="1">26957956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2002 Apr;66(4):389-93</RefSource><PMID Version="1">12164293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2008 Oct;37(5):1158-60</RefSource><PMID Version="1">18832388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2014 Nov;61(1 Suppl):S45-57</RefSource><PMID Version="1">25086286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2013 Apr;57(4):1333-42</RefSource><PMID Version="1">23172780</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017088" MajorTopicYN="N">AIDS-Related Opportunistic Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="N">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018937" MajorTopicYN="N">Hepatitis C Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019698" MajorTopicYN="N">Hepatitis C, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014505" MajorTopicYN="N">Urban Population</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4977883</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ghana</Keyword><Keyword MajorTopicYN="N">HCV</Keyword><Keyword MajorTopicYN="N">Hepatitis C</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Systematic reviews</Keyword><Keyword MajorTopicYN="N">Viral infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27507267</ArticleId><ArticleId IdType="doi">10.1186/s12879-016-1708-7</ArticleId><ArticleId IdType="pii">10.1186/s12879-016-1708-7</ArticleId><ArticleId IdType="pmc">PMC4977883</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Ghana</li></country></list><tree><country name="Ghana"><noRegion><name sortKey="Agyeman, Akosua Adom" sort="Agyeman, Akosua Adom" uniqKey="Agyeman A" first="Akosua Adom" last="Agyeman">Akosua Adom Agyeman</name></noRegion><name sortKey="Ashiagbor, George" sort="Ashiagbor, George" uniqKey="Ashiagbor G" first="George" last="Ashiagbor">George Ashiagbor</name><name sortKey="Mprah, Andy" sort="Mprah, Andy" uniqKey="Mprah A" first="Andy" last="Mprah">Andy Mprah</name><name sortKey="Ofori Asenso, Richard" sort="Ofori Asenso, Richard" uniqKey="Ofori Asenso R" first="Richard" last="Ofori-Asenso">Richard Ofori-Asenso</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000146 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000146 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27507267
|texte= Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27507267" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |